RecruitingNot ApplicableNCT07378839

Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting

Sponsor

University of Minnesota

Enrollment

100 participants

Start Date

Feb 10, 2026

Study Type

INTERVENTIONAL

Conditions

Nausea Pregnancy Emesis

Summary

This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.

Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria4

Pregnant individuals aged 18 years or older
Viable pregnancy with a gestational age between 6 0/7 - 12 6/7 weeks of gestation, confirmed by last menstrual period or ultrasound
Diagnosed with mild to moderate NVP (PUQE-24 score between 4-12)
Ability to understand and read English

Exclusion Criteria5

Severe nausea and vomiting, defined as a PUQE score \>12, or diagnosis of hyperemesis gravidarum requiring hospitalization or intravenous fluid therapy
Pre-existing, active or acute respiratory conditions (e.g., asthma, COPD)
History of severe anxiety disorders affecting breathing patterns
Known deviated nasal septum
Nausea and vomiting that pre-dates the pregnancy or is suspected to be due to a etiology other than pregnancy

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.